ICFO has now used the LUCA platform to characterize the thyroid tissue with simultaneous anatomical measurements, the first ...

Viridian Therapeutics, Inc.'s stock soars on positive trial results, analysts bullish on FDA approval in 2026. Read more on ...

The company’s chronic thyroid eye disease treatment, veligrotug, was able to reduce eye bulge by 56% compared with placebo.

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

The company’s stock could continue to see upward momentum, especially if upcoming trials, such as those for VRDN-003, yield positive results. The potential approval of veligrotug could lead to a ...

Viridian (VRDN) shares shot up 25% after the company reported positive results from a Phase 3 study of veligrotug in the ...

Novo Nordisk is investing $1.2 billion in a rare disease drugs facility in Denmark, weight-loss drugs surge American ...

Taking to TikTok, Dr SK aka @yourdailydoc, stressed "feeling tired all the time is your body’s way of telling you there is ...

This essential mineral is needed by your thyroid gland to produce hormones that regulate your body's metabolic rate. If you ...

In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...

Ragi, a nutrient-rich grain, is gaining popularity as a healthy alternative to wheat. While wheat offers fiber, protein, and ...